Related references
Note: Only part of the references are listed.Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients
Eliana Bignotti et al.
FRONTIERS IN ONCOLOGY (2020)
Diagnostic and prognostic role of HE4 expression in multiple carcinomas
Chellan Kumarasamy et al.
MEDICINE (2019)
The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer
Jingxuan Fu et al.
RADIATION ONCOLOGY (2019)
Knockdown of HE4 suppresses aggressive cell growth and malignant progression of ovarian cancer by inhibiting the JAK/STAT3 pathway
Aihong Wang et al.
BIOLOGY OPEN (2019)
Current Status of and Perspectives on Cervical Cancer Screening in Korea
Sung-Chul Lim et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2019)
Cervical Cancer Markers: Epigenetics and microRNAs
Vishuda Laengsri et al.
LABORATORY MEDICINE (2018)
Cervical Cancer Markers: Epigenetics and microRNAs
Vishuda Laengsri et al.
LABORATORY MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates
Karen Couvreur et al.
BMC CANCER (2018)
Cancer of the cervix uteri
Neerja Bhatla et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)
Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients
Aneta Cymbaluk-Ploska et al.
ONCOTARGETS AND THERAPY (2017)
The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study
Mani Nassir et al.
TUMOR BIOLOGY (2016)
Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer
Liancheng Zhu et al.
ONCOTARGET (2016)
Determination of reference intervals of serum levels of human epididymis protein 4 (HE4) in Chinese women
Yaping Tian et al.
JOURNAL OF OVARIAN RESEARCH (2015)
Overexpression of Lewis y antigen promotes human epididymis protein 4-mediated invasion and metastasis of ovarian cancer cells
Huiyu Zhuang et al.
BIOCHIMIE (2014)
Human Epididymis Protein 4 Inhibits Proliferation of Human Ovarian Cancer Cells Via the Mitogen-Activated Protein Kinase and Phosphoinositide 3-Kinase/AKT Pathways
Xiuli Kong et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma
Sami K. Saarelainen et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
Serum HE4 levels combined with CE CT imaging improve the management of monitoring women affected by epithelial ovarian cancer
Lucia Manganaro et al.
ONCOLOGY REPORTS (2013)
Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age
Richard G. Moore et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
HE4 is an independent prognostic marker in endometrial cancer patients
Irene Mutz-Dehbalaie et al.
GYNECOLOGIC ONCOLOGY (2012)
New insights into cervical cancer screening
Jonathan D. Boone et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2012)
High preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancer
Grigorios Kalapotharakos et al.
JOURNAL OF OVARIAN RESEARCH (2012)
HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases
Rafael Molina et al.
TUMOR BIOLOGY (2011)
Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts
K. Huhtinen et al.
BRITISH JOURNAL OF CANCER (2009)
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
Richard G. Moore et al.
GYNECOLOGIC ONCOLOGY (2009)
The Utility of Serum Human Epididymis Protein 4 (HE4) in Patients With a Pelvic Mass
Martina Montagnana et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2009)
Comprehensive analysis of HE4 expression in normal and malignant human tissues
Mary T. Galgano et al.
MODERN PATHOLOGY (2006)
The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms
L Bingle et al.
ONCOGENE (2002)
Share Paper
